A Study to Evaluate the Efficacy and Safety of AD-208

  • STATUS
    Recruiting
  • End date
    Dec 1, 2022
  • participants needed
    130
  • sponsor
    Addpharma Inc.
Updated on 23 November 2021

Summary

The purpose of this study is to evaluate the efficacy and safety of AD-208.

Description

The purpose of this study is to evaluate the efficacy and safety of AD-208 in male patients with androgenetic alopecia.

Details
Condition Hair Loss, androgenic alopecia, Male Pattern Baldness, Alopecia
Treatment AD-208, AD-2081, placebo of AD-208, placebo of AD-2081
Clinical Study IdentifierNCT04825561
SponsorAddpharma Inc.
Last Modified on23 November 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Male patients aged 18-50 years, inclusive
Patients who meet the appropriate criteria according to the classification of hair loss
Signed informed consent

Exclusion Criteria

Patients with hair loss disorders other than androgenetic alopecia
Other exclusions applied
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note